Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Gary Oderda"'
1
Akademický článek
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods
Autor: Joseph Biskupiak, Gary Oderda, Diana Brixner, Todd L Wandstrat
Publikováno v: Journal of Comparative Effectiveness Research, Vol 13, Iss 5 (2024)
Background: In the absence of head-to-head comparative data from randomized controlled trials, indirect treatment comparisons (ITCs) may be used to compare the relative effects of treatments versus a common comparator (either placebo or active trea
Externí odkaz: https://doaj.org/article/9ca967bbd9764ce9a424cbb9c6190996
Zobrazit plný text záznamu
2
Akademický článek
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare Patients
Autor: Vincent Garmo, Xiaohui Zhao, Carmen D. Ng, Aimee Near, Tania Banerji, Keiko Wada, Gary Oderda, Diana Brixner, Joseph Biskupiak, Ferhina S. Ali, Archad M. Khanani, Alicia Menezes, Ibrahim M. Abbass
Publikováno v: Journal of Health Economics and Outcomes Research, Vol 11, Iss 1 (2024)
**Background:** The association of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) with functional status in the general Medicare population are not well established. **Objectives:*
Externí odkaz: https://doaj.org/article/8201ae55545b4009b4cb747fcd449ac8
Zobrazit plný text záznamu
3
Akademický článek
Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 Diabetic Patients within a Long-Term Care Setting
Autor: Ning Wu, Xia Yu, Mallik Greene, Gary Oderda
Publikováno v: International Journal of Nephrology, Vol 2014 (2014)
This retrospective study assessed the prevalence of moderate to severe chronic kidney disease (CKD) among nursing home (NH) residents with type 2 diabetes. The pattern of oral antidiabetic drug (OAD) use and their concordance with the National Kidney
Externí odkaz: https://doaj.org/article/7f48e78f881642189bdc8b3155a65e5f
Zobrazit plný text záznamu
4
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a
Autor: Beilei, Cai, Zheng-Yi, Zhou, Weiguang, Xue, Nisha C, Hazra, Mukesh, Singh, Dinesh, Mishra, Diana, Brixner, Gary, Oderda, Joseph, Biskupiak
Publikováno v: Journal of medical economics. 24(1)
To estimate the budget impact of adding capmatinib, the first FDA approved MET inhibitor, to a US commercial or Medicare health plan for patients with metastatic non-small cell lung cancer (mNSCLC) whose tumors have a mutation that leads toTarget pop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::accaf0be5f6d18b2438beb9802281597
https://pubmed.ncbi.nlm.nih.gov/33397178
Zobrazit plný text záznamu
7
Akademický článek
How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs.
Autor: Robert J. Valuck, Elaine H. Morrato, Sheri Dodd, Gary Oderda, Dean G. Haxby, Richard Allen
Publikováno v: Current Medical Research & Opinion; Oct2007, Vol. 23 Issue 10, p2567-2576, 10p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje